Collegium Pharmaceutical, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | $2.2M | $-23.2M | $-23.1M |
| Jun 2017 | $3.6M | $-21.3M | $-21.1M |
| Sep 2017 | $12.0M | $-13.4M | $-13.3M |
| Dec 2017 | $10.8M | $-17.6M | $-17.4M |
| Mar 2018 | $63.7M | $-13.2M | $-18.7M |
| Jun 2018 | $73.1M | $-7.3M | $-13.1M |
| Sep 2018 | $70.2M | $-11.2M | $-16.5M |
| Dec 2018 | $73.4M | $11.0M | $9.1M |
| Mar 2019 | $74.5M | $-10.0M | $-9.7M |
| Jun 2019 | $75.0M | $-5.0M | $-4.7M |
| Sep 2019 | $72.9M | $-6.4M | $-6.1M |
| Dec 2019 | $74.2M | $-2.4M | $-2.2M |
| Mar 2020 | $76.5M | $5.1M | $450.0K |
| Jun 2020 | $78.1M | $16.5M | $8.1M |
| Sep 2020 | $79.2M | $19.6M | $11.3M |
| Dec 2020 | $76.3M | $15.0M | $7.0M |
| Mar 2021 | $87.7M | $21.2M | $15.7M |
| Jun 2021 | $82.9M | $16.4M | $72.8M |
| Sep 2021 | $78.8M | $14.1M | $8.0M |
| Dec 2021 | $27.4M | $-34.1M | $-25.0M |
| Mar 2022 | $83.8M | $-10.0M | $-13.1M |
| Jun 2022 | $123.5M | $11.1M | $-5.2M |
| Sep 2022 | $127.0M | $20.5M | $457.0K |
| Dec 2022 | $129.6M | $11.8M | $-7.2M |
| Mar 2023 | $144.8M | $24.6M | $-17.4M |
| Jun 2023 | $135.5M | $35.6M | $13.0M |
| Sep 2023 | $136.7M | $45.0M | $20.6M |
| Dec 2023 | $149.7M | $61.7M | $31.9M |
| Mar 2024 | $144.9M | $49.5M | $27.7M |
| Jun 2024 | $145.3M | $47.5M | $19.6M |
| Sep 2024 | $159.3M | $34.8M | $9.3M |
| Dec 2024 | $181.9M | $38.1M | $12.5M |
| Mar 2025 | $177.8M | $21.7M | $2.4M |
| Jun 2025 | $188.0M | $35.1M | $12.0M |
| Sep 2025 | $209.4M | $62.1M | $31.5M |
| Dec 2025 | $205.4M | $60.8M | $17.0M |
| Mar 2026 | $193.5M | $30.9M | $14.5M |
| Jun 2026 | $199.9M | $3.7M | $-15.1M |